Business, energy, technology, markets and global industry news from Business News Today

contract development and manufacturing organization

Pharma & Biotech

What OrganaBio’s Excellos asset acquisition reveals about next-generation CDMO demand

Cell therapy needs redundancy, not just cleanrooms. OrganaBio’s Excellos deal tests whether bicoastal CDMO scale can reduce developer risk.

Read More
Pharma & Biotech

Why Vetter’s Saarlouis expansion matters for sterile injectable supply chains

Injectable capacity is tightening. Vetter’s Saarlouis bet shows why Europe wants more control over sterile drug manufacturing.

Read More
Pharma & Biotech

Why Forma Life Sciences’ U.S. CDMO launch signals renewed momentum in domestic oral solid drug manufacturing

Forma Life Sciences launches a U.S. CDMO focused on oral solid drug manufacturing. Discover what the move means for pharma supply chains and drug development.

Read More